Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

2.

The Protective Effect of Hispanic Ethnicity on Chronic Obstructive Pulmonary Disease Mortality is Mitigated by Smoking Behavior.

Kinney GL, Thomas DS, Cicutto L, Newman LS, Lutz S, Hokanson JE.

J Pulm Respir Med. 2014 Dec;4(6). pii: 220. Epub 2014 Nov 25.

3.

Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage.

Li FS, Zhang YL, Li Z, Xu D, Liao CY, Ma H, Gong L, Su J, Sun Q, Xu Q, Gao Z, Wang L, Jing J, Wang J, Jiang M, Tian G, Hasan B.

Exp Ther Med. 2016 Oct;12(4):2477-2488. Epub 2016 Sep 6.

4.

Prevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination survey.

Park H, Jung SY, Lee K, Bae WK, Lee K, Han JS, Kim S, Choo S, Jeong JM, Kim HR, Ro HJ, Jeong H.

Korean J Fam Med. 2015 May;36(3):128-34. doi: 10.4082/kjfm.2015.36.3.128. Epub 2015 May 22.

5.

Enhancement of COPD biological networks using a web-based collaboration interface.

sbv IMPROVER project team (in alphabetical order), Boue S, Fields B, Hoeng J, Park J, Peitsch MC, Schlage WK, Talikka M; Challenge Best Performers (in alphabetical order), Binenbaum I, Bondarenko V, Bulgakov OV, Cherkasova V, Diaz-Diaz N, Fedorova L, Guryanova S, Guzova J, Igorevna Koroleva G, Kozhemyakina E, Kumar R, Lavid N, Lu Q, Menon S, Ouliel Y, Peterson SC, Prokhorov A, Sanders E, Schrier S, Schwaitzer Neta G, Shvydchenko I, Tallam A, Villa-Fombuena G, Wu J, Yudkevich I, Zelikman M.

Version 2. F1000Res. 2015 Jan 29 [revised 2015 May 20];4:32. doi: 10.12688/f1000research.5984.2. eCollection 2015.

6.

The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial.

Wilson AM, Browne P, Olive S, Clark A, Galey P, Dix E, Woodhouse H, Robinson S, Wilson EC, Staunton L.

BMJ Open. 2015 Mar 11;5(3):e005921. doi: 10.1136/bmjopen-2014-005921.

7.
8.

Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.

Inghammar M, Engström G, Ljungberg B, Löfdahl CG, Roth A, Egesten A.

BMC Infect Dis. 2014 Mar 25;14:163. doi: 10.1186/1471-2334-14-163.

9.

Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature.

Andreou G, Vlachos F, Makanikas K.

Sleep Disord. 2014;2014:768210. doi: 10.1155/2014/768210. Epub 2014 Feb 6. Review.

10.

Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B; ProHOSP Study Group.

BMC Infect Dis. 2013 Dec 11;13:585. doi: 10.1186/1471-2334-13-585.

11.

Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.

Lambert JA, Raju SV, Tang LP, McNicholas CM, Li Y, Courville CA, Farris RF, Coricor GE, Smoot LH, Mazur MM, Dransfield MT, Bolger GB, Rowe SM.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):549-58. doi: 10.1165/rcmb.2013-0228OC.

12.

The standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease.

Jung KH, Haam KK, Park S, Kim Y, Lee SR, Lee G, Kim M, Hong M, Shin M, Jung S, Bae H.

BMC Complement Altern Med. 2013 Sep 5;13:219. doi: 10.1186/1472-6882-13-219.

13.

Chronic obstructive pulmonary disease in China: the potential role of indacaterol.

Gao J, Prasad N.

J Thorac Dis. 2013 Aug;5(4):549-58. doi: 10.3978/j.issn.2072-1439.2013.08.04.

14.

Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.

Pandey R, Singh M, Singhal U, Gupta KB, Aggarwal SK.

J Clin Diagn Res. 2013 Mar;7(3):580-8. doi: 10.7860/JCDR/2013/4360.2832. Epub 2013 Mar 1.

15.

Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study.

Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, Chao KM.

BMC Infect Dis. 2013 Apr 30;13:194. doi: 10.1186/1471-2334-13-194.

16.

Increased cytokines response in patients with tuberculosis complicated with chronic obstructive pulmonary disease.

Tang S, Cui H, Yao L, Hao X, Shen Y, Fan L, Sun H, Zhang Z, Huang JA.

PLoS One. 2013 Apr 23;8(4):e62385. doi: 10.1371/journal.pone.0062385. Print 2013.

17.
18.

Cigarette smoke suppresses the surface expression of c-kit and FcεRI on mast cells.

Givi ME, Blokhuis BR, Da Silva CA, Adcock I, Garssen J, Folkerts G, Redegeld FA, Mortaz E.

Mediators Inflamm. 2013;2013:813091. doi: 10.1155/2013/813091. Epub 2013 Feb 12.

19.

Self-management support for moderate-to-severe chronic obstructive pulmonary disease: a pilot randomised controlled trial.

Taylor SJ, Sohanpal R, Bremner SA, Devine A, McDaid D, Fernández JL, Griffiths CJ, Eldridge S.

Br J Gen Pract. 2012 Oct;62(603):e687-95. doi: 10.3399/bjgp12X656829.

20.

Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.

Lee H, Kim Y, Kim HJ, Park S, Jang YP, Jung S, Jung H, Bae H.

Evid Based Complement Alternat Med. 2012;2012:769830. doi: 10.1155/2012/769830. Epub 2012 Jun 12.

Supplemental Content

Support Center